Navigation Links
Microtest Labs Adds Dissolution Testing to its Suite of Analytical and Stability Testing Services
Date:4/1/2009

AGAWAM, Mass., April 1 /PRNewswire/ -- Microtest Laboratories, a leading single source provider of contract analytical solutions, is adding dissolution testing to its current suite of analytical testing and stability services.

"The addition of dissolution testing is the perfect complement to our portfolio of services," said Steven Richter, Ph. D., President and Scientific Founder of Microtest Laboratories (www.microtestlabs.com). "By offering an even more comprehensive array of assays, we're increasing the convenience, efficiency, and value that we deliver as a single, preferred provider of contract laboratory services."

Dissolution is a compendial method used to measure a drug's rate of release from its dosage form. It is a complement to other analytical assays - potency and related substances (Microtest already offers both) - that characterize the dosage form.

Dissolution is typically used:

  • To optimize drug delivery rate during development studies
  • For use in routine QC analysis for lot release and to measure lot-to-lot variability
  • For use in stability studies to study the effects of time/temperature/humidity on the dosage form
  • To compare one dosage form to another (different formulations, different processes, analysis of competitor's samples)
  • To estimate release and absorption rates in humans after an in vitro - in vivo correlation is established

Dissolution is a sample preparation technique. Samples still need to be analyzed separately, usually by Microtest's HPLC or UV Spectroscopy testing. Typical samples are oral dosage forms, although it can also be used on topicals and transdermal systems.

In addition to dissolution testing, Microtest provides a host of analytical assays, including HPLC Assays, GC Analysis, Protein Analysis, FTIR Analysis, and UV/VIS Analysis.

Microtest's analytical testing processes follow guidelines from all major standards authorities, including the United States Pharmacopeia (USP), the Japanese and European Pharmacopoeias, the U.S. Food and Drug Administration (FDA), the International Organization for Standardization (ISO), and the Association for Advancement of Medical Instrumentation (AAMI).

Visit the Microtest website at www.microtestlabs.com, or call 1-800-631-1680.

About Microtest

Microtest is a leader in testing services and contract manufacturing for the medical device, pharmaceutical, biotechnology industries. Based in Agawam, Massachusetts, USA, the company's expertise and flexible processes enhance product safety and security, accelerate time to market, and minimize supply chain disruption. For more information, visit www.microtestlabs.com or call 1-413-786-1680 or toll-free 1-800-631-1680.

Download high resolution photos from: www.microtestlabs.com/photos

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Steve Richter, Ph.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=42622


'/>"/>
SOURCE Microtest
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Microtest Labs Offers Free Microbial Identification Testing, Free Shipping on Other Tests, to MD&M West Attendees
2. Microtest Labs Doubles Microbial Identification, Analytical Services
3. Microtest Offers Free White Paper: Virus Testing for Biological Products: Partnering With a Contract Lab
4. Varian Medical Systems to Exhibit X-ray and CT Technologies for Non-Destructive Testing at the Upcoming ASNT 18th Annual Spring Conference
5. Celsis In Vitro Technologies and Promega to Offer Fast, Reliable Solutions for ADME-Tox Testing With Primary Hepatocytes
6. MODA Offers Paperless QC Micro Webinar Series on Automating Environmental Monitoring, Utility and Product Testing
7. DiFUSION Technologies Completes Successful Testing of Antimicrobial Spinal Implant
8. Free White Papers Detail Sterility Testing Essentials for Medical Device, Pharmaceutical Manufacturers
9. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
10. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
11. Newly Available To Medical Device Manufacturers - Bluetooth Testing Equipment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... -- Beike Biotechnology, the Shenzhen ... in late 2015 to mark their successful combined efforts ... --> --> The signing, ... Therapy" was hosted by the Shenzhen Cell Bank and ... Beike Biotechnology Co., Ltd. Shenzhen,s ...
(Date:2/4/2016)... , February 4, 2016 ... a biotechnology acceleration company is pleased to provide the following ... --> Over the last 3 months we have ... securities purchase agreements exceeding $1,000,000. As a result, we have ... Mannin Research Inc. license agreement and expect that development to ...
(Date:2/4/2016)... Feb. 4, 2016 Sinovac Biotech Ltd. ("Sinovac" ... provider of biopharmaceutical products in China ... board of directors received on February 4, 2016 a ... a consortium comprised of PKU V-Ming ( Shanghai ... Ltd., CICC Qianhai Development ( Shenzhen ) ...
(Date:2/4/2016)... ... February 04, 2016 , ... Many of the engineers at FireflySci, ... What sets them apart from other cuvette manufacturers is their supercharged customer service ... On top of this steady flow of inside information, they have recently revamped ...
Breaking Biology Technology:
(Date:2/2/2016)... Technology Enhancements Accelerate Growth of X-ray Imaging ... and computed radiography markets in Thailand ... Indonesia (TIM). It provides an in-depth analysis ... as regional market drivers and restraints. The study offers ... market attractiveness, both for digital and computed radiography. Market ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
(Date:1/28/2016)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human ... December 31, 2015. --> --> ... 2 percent compared to the comparable quarter last year to $470.5 ... $35.0 million, or $0.93 per diluted share. ... quarter of fiscal 2016 grew 9 percent over the prior year ...
Breaking Biology News(10 mins):